Background and objective: The objective of this study was to enumerate total cells and the number of inflammatory cell differentials in large airways (LAs) versus small airways (SAs) of mild-moderate COPD, and against appropriate controls. Methods: For LA, we used endobronchial biopsies and for SA resected lung tissues. Immunostaining was enumerated (cells per mm 2 ) for macrophages, neutrophils, CD4 and CD8 T cells in the lamina propria (LP) up to 150 μM deep for LA and full wall thickness for SA. Results: We confirmed hypocellularity in the LA and in the SA wall in smokers and COPD (P < 0.001). LA cellularity was least in current smokers with COPD (COPD-CS) (P < 0.01), while SA cellularity was similar across smoker/COPD groups. LA neutrophils were decreased in COPD-CS (P < 0.01), while SA neutrophil counts were unchanged. Compared with controls, LA macrophage numbers in COPD were significantly lower (P < 0.05), with SA macrophage numbers unchanged. A significant increase was observed in SA CD8+ cells in both normal smokers (P < 0.01) and COPD-CS (P < 0.001) but not in LA. Conclusion: These unique data indicate that the current model for airway wall inflammation in COPD is oversimplified, and contrast with innate inflammatory activation in the lumen, at least in mild-moderate disease. Any abnormalities in airway wall cell differentials are small, although exaggerated in percentage terms.
INTRODUCTION
COPD is a devastating global disease caused especially by cigarette smoking. The disease is characterized as slowly progressive fixed airway narrowing due to small airway (SA) fibrosis and obliteration. Up to 50% of COPD patients also go on to varying degree of emphysema, 1 and as a group, they are highly vulnerable to lung cancer, suggesting a common pathogenesis. 2 The literature has reported convincing increases in both innate and adaptive cells in the airway lumen in COPD. [3] [4] [5] It has also become accepted that airway wall inflammation also plays a critical role in COPD, but the evidence for this is quite limited. Better understanding of COPD pathophysiology requires more detailed information from airway wall tissues. 6 There are reports of both increases and decreases in inflammatory cell profiles in the airway wall. [7] [8] [9] Selection of patients, inadequate approaches to controls and different sources of tissue acquisition have been important variables. Studies aimed at relatively early disease before secondary complications such as chronic infection and cancer would be valuable for understanding fundamental pathogenesis. 
SUMMARY AT A GLANCE
The study is the first to describe hypocellularity in the airway wall tissue of mild-moderate COPD subjects and a corresponding reduction in key innate inflammatory cell populations. Our current observation contests the currently held simplistic description of airway wall inflammation in smokers/COPD, and has implications for current therapeutics.
We have reported previously that smoking significantly decreased large airway (LA) lamina propria (LP) total cellularity in mild-moderate COPD subjects.
10 Surprisingly, few groups have examined this in airway tissue. Our hypocellularity finding in LA biopsies questioned whether COPD can truly be regarded as an 'airway wall' inflammatory disease. The limited literature evidence on cell differentials in the airway wall is also variable; thus, O'Shaughnessy et al. 11 showed that there was an increase in CD8+ T cells in COPD while the same cells were demonstrated to decrease progressively from mild-moderate to severe COPD by Di Stephano et al., and reports on macrophages and neutrophils have similarly varied in both directions. 4, 7, 12, 13 This inconsistency for cell differentials in the airway wall and the previous finding of overall hypocellularity led us to believe that a new thorough, systematic investigation was warranted.
We have also probed in more detail than previously about the phenotypic specificity of the commonly used macrophage marker CD68 that has been used rather uncritically by respiratory scientists for many years. Evidence from non-respiratory researchers suggests that this marker is not only unique to macrophages alone but is also expressed on fibroblastic cells. 14 In the current study, we provide total cellularity, 'inflammatory' cell differentials for neutrophils, CD68+ and CD8+ cells in both LA and SA tissue from mildmoderate, stable COPD subjects who were not on medication, and free from clinical infection.
METHODS

Study participants
Information on the study participants is provided in Table 1 . This study was approved by the Tasmania Health & Medical Human Research Ethics Committee (EC00337).
LA endobronchial biopsies
A total of 72 volunteers were recruited through advertisement. LA endobronchial biopsies (Ebbs) from 20 normal lung function smokers (NLFSs), 13 current smokers with COPD (COPD-CS) and 14 ex-smokers with COPD (COPD-ES) were compared with 25 healthy non-smokers. COPD was diagnosed according to GOLD (2006) criteria. Subjects with other respiratory diseases, a history of recent acute exacerbation of COPD and on systemic or inhaled corticosteroids were excluded from the study.
SA resected tissues
A total of 40 patients consented for inclusion in this study. The subjects all had primary non-small cell lung cancer (NSCLC), with an approximately equal distribution of squamous and adenocarcinoma. Eighteen demonstrated GOLD stage I/II COPD on spirometry (FER < 70%) and were classified as current or exsmokers (12 months since smoking cessation). Eleven individuals were current smokers with no evidence of airflow obstruction (NLFS). Subjects with systemic or inhaled corticosteroids were excluded from the study. Tissue from 10 non-smokers was obtained from Professor Jim Hogg's Biobank at the University of British Columbia and included as a normal control (NC) group for comparison.
Tissue processing
Ebb from the LA and surgical resections away from the primary tumour, and containing non-cancer affected SA, and NC tissues were fixed in formalin within minutes of surgery. At processing, tissue blocks of the LA and SA (<2 mm internal diameter) were embedded in paraffin.
Immunostaining
Sections were cut at 3 μM from individual paraffinembedded blocks. Immunostaining was performed for neutrophils with anti-human neutrophil elastase (1:100 dilution) (Dako, USA, clone NP57, catalogue # M0752), macrophages with anti-human CD68 (1:400 dilution) (Dako, USA, clone KP1, catalogue # M0814), CD8 and CD4 T cells with anti-CD8 (Leica Novo Castra, UK, clone 4B11, catalogue # NCL-CD8-4B11) and anti-CD4 (Leica Novo Castra, UK, clone 1F6, catalogue # NCL-CD8-4B11) (1:20 dilution) antibodies, respectively, for 1 h at room temperature. Species-appropriate isotypematched IgG (X0931 clone DAK-GO1; Dako) was incorporated. Bound antibodies were elaborated using peroxidase-labelled Envision (catalogue # K4001; Dako) and DAB (catalogue # K3468; Dako).
Tissue quantification
Computer-assisted image analysis was performed with a Leica DM 2500 microscope, Leica DFC495 camera (Leica Microsystems, Germany) and Image Pro Plus 7.0 (Media Cybernetics, USA) software. For the LA, four airway wall biopsies per subject taken from around the origin of the right lower lobe bronchi were analysed. Two adequate sections were evaluated per biopsy, and then five random fields were chosen for comprehensive analysis without ad hoc area selection, but muscle bundles and glands were excluded from the area surveyed.
The observer was blinded to the subjects and diagnoses.
Stained cells were counted in the LP up to 150 μ deep for LA and full thickness airway wall (or up to 100 μ deep) in the SA wall; cells per mm 2 area were calculated. Stained cells in the epithelium and reticular basement membrane (Rbm) were counted and presented per mm of Rbm length. For total cell counts, haematoxylin-stained nuclei were considered as an individual cell, and measured with similar strategies mentioned above.
Statistical analysis
On the basis of distributions, data here are represented as mean plus SD, or as medians plus ranges; one-way analysis of variance (ANOVA) parametric tests (Tukey, comparing means across groups) or non-parametric (Kruskal-Wallis, comparing medians across groups of interest) tests were performed. Specific group differences were then explored as appropriate according to Reduced cellularity in COPD airway wall prior hypotheses and the structure of the data using the two-tailed t-test or Mann-Whitney U-test.
RESULTS
Total cells
Cell density was greater in SA and LA in NCs (P < 0.01), with cells per mm 2 of LP compared to diseased. A decrease in overall cell numbers was observed in both LA LP (P < 0.01) and SA wall (P < 0.001) in COPD when compared with normal non-smokers. In NLFS in LA, TC numbers were intermediate (P < 0.01) while in ex-smokers the cell numbers were essentially back to NC levels although with wider variation (P = 0.15). In the SA, TC numbers were significantly fewer compared with NCs in all smoker/COPD groups with little difference between these three (Fig. 1A,B) .
Neutrophils
Neutrophil numbers were similar between the SA and LA in NC. Neutrophil numbers in the pathological groups in LAs reflected the changes in total cell counts, that is they were reduced with least density observed in COPD-CS (P < 0.01). In SA, however, neutrophil density was little different from normal in all groups, even if apparently (non-significantly) slightly reduced in the NLFS (Fig. 1C,D) .
CD68+ cells
We observed two morphologically variable populations of CD68+ cells: round macrophages and spindleshaped cells, which we will refer to as macrophages and fibroblast-like cells, respectively ( Fig. 2A,B) . In normal LA, these CD68+ fibroblast-like cells were much more numerous than macrophages, but in contrast, macrophages dominated the SA CD68+ profile (Figs 2C,D, 3) .
In COPD-CS LA, compared with NCs, we found fewer macrophages (P < 0.05), while in contrast, macrophages in the NLFS were significantly higher (P < 0.001) than NCs. In COPD-ES subjects, macrophages numbers were close to normal levels. In SA, although macrophage numbers were generally high, we found no significant change from normal in their numbers in smoker/COPD groups (Fig. 3) .
Fibroblast-like cells were slightly higher in normal LA than normal SA but not significantly (P = 0.09). Generally, there was a reduction in all smoker/COPD groups in LAs (significant only for NLFS, P < 0.01) but fibroblast-like cell densities were unchanged in corresponding SAs (Fig. 3) .
Lymphocytes
In the LA wall, the lymphocyte populations studied were dominated by the CD8+ phenotype. Both CD8+ and CD4+ T cells were found to be lower than normal in the smoker/COPD groups but with some substantial changes in their ratio, especially in the COPD-CS where there was an even more marked relative excess of CD8+ over CD4+ lymphocytes (Fig. 4D ).
There were many fewer CD4+ T cells throughout the airways, and indeed so few in the SA that we did not formally count them. In contrast in SA, CD8+ cells tended to be higher than normal across all clinical groups, and especially so in COPD-CS (P < 0.01).
Inflammatory cells in airway epithelium and Rbm
Overall, the inflammatory cell densities in the airway epithelium and Rbm were far lower in comparison to the LP. Although the absolute number was small, a significant increase above normal was observed for macrophages in the epithelium of NLFS when compared with NC (Table 2) .
DISCUSSION
In contrast to the current belief of COPD pathology being primarily an inflammatory airway disease, we have found that the main finding in the COPD 'airway wall' is the reduction in total cellularity at least in the mild-moderate disease. This overall decrease was accompanied by quite small fluctuations in specific inflammatory cell types; the most marked change was a general increase in macrophages in the SA wall compared with the LA, but this was in both healthy controls as well as in the diseased. Changes in neutrophil numbers largely tracked total cell counts. In the COPD LA wall, CD8+ T cells were the dominant lymphocyte phenotype over CD4+ T cells, and were the only cell type found to be significantly increased in COPD in the SA wall.
These data are unique in their comprehensive nature, although the importance of sampling the airway wall has been emphasized as needed to complement more easily obtained luminal cell counts in BAL or sputum. 15, 16 The activation of an innate neutrophil and macrophage reaction in the airway lumen in COPD seems more consistent, although, here too, there have been conflicting reports, as encompassed by previous reviews. 16 This may be because of smoking itself or secondary to infection, which may have a crucial role. 3, 5, 17 In the current study, however, our focus has been to analyse the role of key inflammatory cells in the airway wall of COPD subjects, where previous reports have been plagued by inconsistencies. 16 This review 16 strongly recommended that a thorough study of airway wall innate cellularity be done, and it has taken a decade for this to appear.
An earlier report 7 suggested a moderate increase in the number of neutrophils in the sub-epithelial airway wall LP in LA biopsies in mild-moderate COPD in comparison to smokers, but this finding is difficult to evaluate as there was no control group. Our study suggests, in contrast, that in the airway wall, the neutrophils are reduced in stable COPD subjects especially in the LA LP. Our data also suggest that the neutrophils tend back towards normal levels in COPD-ES, suggesting mainly a smoking and to a lesser extent a COPD effect.
For the SA, published neutrophil data are both limited and contradictory. Studies conducted by Lams et al. 12 suggested no change in smokers, which was similar to the conclusion of Hogg et al. in mild COPD subjects, 18 while more recent evidence suggested a small increase in neutrophil numbers in mild-moderate COPD patients. 13 Our findings again showed no significant change in COPD subjects in comparison to either NLFS or NC.
The lack of neutrophilia in the airway wall of smokers and COPD could be hypothesized to active egress of neutrophils into the airway lumen, although there was no obvious gradient of wall neutrophils from deep to superficial (epithelium). 6, 19 We demonstrate a significant decrease in the number of macrophages in the LA wall in COPD. Interestingly, macrophages were increased in NLFS, but it seems doubtful that this reaction is related to COPD development. Our macrophage findings are contrary to those of Di Stephano et al. 7 who suggested a small increase in LA macrophages in COPD, but their study only had smoking controls. In the current study, we have shown morphological variation in cells expressing the CD68 epitope. Thus, we observed two phenotypically distinct populations staining with CD68; one more round, darkly stained and displayed typical macrophages phenotype, while the other more lightly stained, spindly and fibroblast-like. This duality of CD68 staining has been previously shown in other disease tissues and in vitro 14, [20] [21] [22] but so far has received little attention in the respiratory literature.
The SA wall had far greater number of both 'true' tissue macrophages and also the more fibroblast-like CD68+ cells. This would be consistent with SA fibrosis, but this was belied by the uniform numbers across groups with no signal here for COPD. The macrophage phenotypes have been established in recent years; macrophages can exist in the pro-inflammatory, tissuedestructive M1 phenotype and also as a phagocytic, anti-inflammatory and pro-fibrotic M2 phenotype. 23 Preliminary data 24 indicate that in the airway wall there may be phenotype shift from M2 to M1 macrophages, which could be the true inflammatory signal but needs confirmation.
The decrease in both CD8+ and CD4+ T cells in the LA LP in COPD is contradictory to findings from O'Shaughnessy et al., where both CD4+ and CD8+ T cell numbers were said to be increased, at least in those with 'chronic bronchitis'. 11 The difference in result may be a consequence of this phenotypic comorbidity absent in our subjects. However, we are in agreement with another report. 8 Our observations on CD8+ to CD4+ T cell ratios did suggest that the LA wall in COPD is immunologically skewed towards CD8+ T cells, perhaps a response to the susceptibility of COPD patients to airway viral infection. 13, 25 CD8+ T cells were decreased in LA LP with both smoking and COPD, but CD4+ cells' decrease was even more marked. Data are presented as medians (range). ** and * Represents P < 0.01 and P < 0.05 compared with NC, respectively; # represents P < 0.05 compared with NLFS; -represents not done.
COPD-CS, current smoker with COPD; COPD-ES, ex-smoker with COPD; LA, large airway; NC, normal control; NLFS, normal lung function smoker; Rbm, reticular basement membrane; SA, small airway.
The current report is limited to the more highly cited 'classical' inflammatory cells. In addition, we have previously observed an increase in mast cells in COPD LA LP 26 and are studying SA mast cells. Others have looked at dendritic cells (CD83+) and found them to be few and variable in number, and reduced essentially to zero in the airways in COPD. 27 Our assessment of CD11c+ dendritic cells in COPD LA LP found them to be too few to analyse. 28 There are even fewer data available on eosinophils in the airway wall of COPD patients, and these are variable and contradictory. 9, 29 In conclusion, we have found that there is a marked decrease in total cellularity in both LA and SA walls of smokers and especially in COPD. This change is reflected in a decrease in some of the key inflammatory cells in the airway wall in these clinical groups. Thus, one may find it hard to defend the prevalent dogma of COPD being an inherently airway wall innate inflammatory disease, with at most a small change in CD8+ to CD4+ T cell balance only in the LA.
